Peptides for Perimenopause Symptoms: Sleep, Joints, and Libido

Perimenopause Is a Cluster, Not One Symptom

Perimenopause is the transition into menopause, and it can run for several years. Estrogen and progesterone do not fall in a straight line during this window, they swing. That variability is why the experience so often shows up as a cluster rather than a single complaint: sleep breaks up, joints and tendons start aching in ways they did not before, desire drops, and daytime energy flattens, frequently all in the same stretch of months.

Junnila RK et al., "The GH/IGF-1 axis in ageing and longevity," Nature Reviews Endocrinology, 2013. View study

Growth hormone output, which has been declining since the late 20s, drops more sharply through the transition, and collagen synthesis slows alongside it. That is the background hum underneath several of these symptoms. Peptides do not replace estrogen or progesterone, and they are not a treatment for menopause. What they can do is target the specific pieces of the cluster one at a time. The rest of this guide walks through them symptom by symptom, because the right starting peptide depends on which part of the cluster is loudest for you.

Sleep: The First Domino

Disrupted sleep is often the first thing women notice, and it makes everything else worse. Falling asleep gets harder, waking at 3am gets more common, and the sleep that does come feels lighter. Some of that is hormonal, and some of it is the natural age-related shift toward less deep slow-wave sleep.

DSIP (Delta Sleep-Inducing Peptide) supports the transition into deep slow-wave sleep without sedation. It is not a sleeping pill and it does not force unconsciousness. It works on sleep architecture, the structure of the night, which is exactly what erodes during the transition. Women who use DSIP tend to report longer uninterrupted stretches and waking up feeling more restored.

Selank is the better fit when the problem is a mind that will not switch off at bedtime. It modulates GABA and serotonin signaling to lower stress reactivity, so it addresses the cause of onset insomnia rather than masking it. If your sleep breaks because of racing thoughts rather than because you cannot stay asleep, Selank is the more targeted choice.

Joint and Tendon Aches

New joint stiffness and tendon aches are common during the transition, and they can appear without any injury to explain them. Declining estrogen affects connective tissue and the inflammatory environment around joints, and collagen synthesis slows with age on top of that.

Shuster S et al., "The influence of age and sex on skin thickness, skin collagen and density," British Journal of Dermatology, 1975. View study

BPC-157 is the standard peptide for joint and connective-tissue complaints. It supports blood-vessel formation at the site, helps tissue repair, and calms the local inflammatory response. For nagging aches that have not responded to rest and movement alone, a BPC-157 protocol often produces meaningful improvement within a few weeks.

When the aches are more widespread than one problem area, the BPC/TB-500 combination adds broader systemic recovery support. TB-500 helps modulate inflammatory signaling across the body while BPC-157 works on specific trouble spots.

Libido and Desire

A drop in desire is one of the least-discussed parts of the transition, and it is rarely just one thing. Poor sleep, lower energy, and shifting hormones all feed into it. That is worth naming, because the peptide option here works on a different pathway than the others in this guide.

PT-141 (bremelanotide) acts on melanocortin receptors in the brain that are involved in sexual desire, rather than on blood flow the way erectile-focused drugs do. It is FDA-approved for premenopausal women with hypoactive sexual desire disorder, based on two randomized phase 3 trials. Because that approval studied premenopausal women, whether PT-141 fits your specific stage of the transition is a provider decision, and it is prescribed after a review of your history rather than reached for casually.

Kingsberg SA et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials," Obstetrics and Gynecology, 2019. View study

Energy and Recovery

The flat, harder-to-shift fatigue of the transition is different from being tired after a bad night. It is a baseline drop in day-to-day energy and in how quickly you bounce back from exertion.

NAD+ supports cellular energy production at the mitochondrial level, which is where that baseline sense of energy is generated. Women often pair it with a sleep peptide, since better nights and better cellular energy compound. PeRx ships NAD+ as a ready-to-use subcutaneous injection, not a nasal spray.

Where Peptides Fit With HRT

The most important framing in this whole guide: peptides are not hormone replacement, and they are not a treatment for menopause. Hormone replacement therapy addresses declining estrogen and progesterone directly, and that is its job. Peptides work on different systems, growth hormone, tissue repair, sleep architecture, and desire pathways. They are commonly used alongside HRT to cover the parts of the symptom cluster that hormones alone do not fully resolve.

If you are already on HRT or considering it, tell your provider so they can coordinate. If you are not a candidate for hormones, peptides may still address specific symptoms, but they are not a hormonal substitute and should not be framed as one. For the broader anti-aging and body-composition picture beyond this symptom cluster, see our companion guide on the best peptides for women over 40.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026